课题基金 / 基金详情

MOLECULAR GENETICS OF MACULAR DEGENERATION

MOLECULAR GENETICS OF MACULAR DEGENERATION
黄斑变性的分子遗传学
批准号:
2711105
负责人:
EDWIN M STONE
金额:
$32.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-06-01 至 2000-05-31

项目摘要

项目成果

EDWIN M STONE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Macular degeneration is the leading cause of legal blindness in patients over the age of 55 in developed countries. In one study, nearly 28% of patients over 75 had some degree of macular degeneration. Other studies have suggested that a significant proportion of macular degeneration is heritable. This makes it possible to use a molecular genetic approach to identify genes that cause macular degeneration. Understanding this common disease at the molecular level has the potential to markedly improve the ability to diagnose and treat it in the future. The broad goal of the work proposed in this grant is to identify specific genes that cause inherited forms of macular disease including the common late-onset form of macular degeneration. The specific aims are to: 1) isolate and characterize the gene that causes Best's disease and refine the chromosomal location of a condition known as Dominant Macular Dystrophy with Flecks; 2) map the disease-causing genes in additional families with early and late-onset (age related) macular diseases; 3) investigate the potential allelic relationship between late-onset macular degeneration and earlier-onset dystrophies; 4) test a panel of "high priority" candidate genes for evidence of involvement in macular disease; and 5) explore the possibility that triplet repeats play a role in macular degeneration.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
Classical and melanopsin photoreception in irradiance detection: negative masking of locomotor activity by light.
辐照度检测中的经典和黑视蛋白光感受:光对运动活动的负掩蔽。
DOI: 10.1111/j.1460-9568.2008.06168.x
发表时间: 2008
期刊: The European journal of neuroscience
影响因子: --
作者: [Thompson,Stewart, Foster,RussellG, Stone,EdwinM, Sheffield,ValC, Mrosovsky,N]
通讯作者: Mrosovsky,N
Which Leber congenital amaurosis patients are eligible for gene therapy trials?
哪些莱伯先天性黑蒙患者有资格接受基因治疗试验?
DOI: 10.1016/j.jaapos.2009.08.006
发表时间: 2009
期刊: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
影响因子: --
作者: [Drack,ArleneV, Johnston,Rebecca, Stone,EdwinM]
通讯作者: Stone,EdwinM
DOI: --
发表时间: 2000-05
期刊: Investigative ophthalmology & visual science
影响因子: 4.4
作者: [A. Lotery;Francis L. Munier;Gerald A. Fishman;R. Weleber;S. Jacobson;Louisa M. Affatigato;B. Nichols;D. Schorderet;V. Sheffield;V. Sheffield;E. Stone]
通讯作者: A. Lotery;Francis L. Munier;Gerald A. Fishman;R. Weleber;S. Jacobson;Louisa M. Affatigato;B. Nichols;D. Schorderet;V. Sheffield;V. Sheffield;E. Stone
Organization of the human IMPG2 gene and its evaluation as a candidate gene in age-related macular degeneration and other retinal degenerative disorders.
人类 IMPG2 基因的组织及其作为年龄相关性黄斑变性和其他视网膜退行性疾病候选基因的评估。
DOI: --
发表时间: 2001
期刊: Investigative ophthalmology & visual science.
影响因子: --
作者: [Kuehn,MH, Stone,EM, Hageman,GS]
通讯作者: Hageman,GS
12
    Unraveling the 10q AMD Risk Locus
    • 批准号:
      9762936
    • 项目类别:
    • 资助金额:
      $49.58万
    • 财政年份:
      2016
    • 负责人:
      EDWIN M STONE
    • 依托单位:
    CRISPR-Cas9 based treatment of dominant retinal degeneration
    • 批准号:
      10380840
    • 项目类别:
    • 资助金额:
      $37.43万
    • 财政年份:
      2016
    • 负责人:
      EDWIN M STONE
    • 依托单位:
    CRISPR-Cas9 based treatment of dominant retinal degeneration
    • 批准号:
      9886365
    • 项目类别:
    • 资助金额:
      $39.49万
    • 财政年份:
      2016
    • 负责人:
      EDWIN M STONE
    • 依托单位:
    Unraveling the 10q AMD Risk Locus
    • 批准号:
      9340188
    • 项目类别:
    • 资助金额:
      $49.58万
    • 财政年份:
      2016
    • 负责人:
      EDWIN M STONE
    • 依托单位:
    海外基金